NPM1 and acute myeloid leukemia: Additionally, the authors empirically measured, by mass spectrometry, the HLA class I and class II immunopeptidomes of 13 primary leukemic samples and two AML cell lines, namely OCI-AML3 and MV4-11, carrying type A NPM1 mutation and FLT3-ITD, respectively.